Freshfields and Homburger advised BIOTRONIK on the deal. BIOTRONIK Group, a leading global medical technology company based in Berlin, Germany, has entered into an agreement to...
Teleflex’s Acquisition Teleflex’s $791 Million Acquisition Of VI Business From BIOTRONIK GroupVascular Intervention Business of BIOTRONIK
Ome Metallurgica Erbese’s Acquisition of Jungeblodt
Freshfields advised shareholders on sale of Jungeblodt group. Ome Metallurgica Erbese (OME), an Italian portfolio company under the umbrella of IGI Private Equity and a producer...
AEA Investors’ Majority Investment in SCIO Automation
Freshfields advised AEA Investors on majority investment in SCIO Automation AEA Investors has recently acquired a majority stake in SCIO Automation, pending approval from relevant antitrust...
Röhm’s Acquisition of SABIC’s Functional Forms Business
Freshfields Bruckhaus Deringer advised Röhm on the deal. Röhm, one of the leading manufacturers in the methacrylates business, executed its acquisition of SABIC’s Functional Forms business....
Verisk’s Acquisition Of ACTINEO
Freshfields Bruckhaus Deringer advised Verisk (Nasdaq:VRSK) on the deal. Allen & Overy advised global investor The Riverside Company Verisk (Nasdaq:VRSK) on its acquisition of ACTINEO, a...
Lanxess’ $1.3 Billion Acquisition of IFF’s Microbial Control Business
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
Cheplapharm Arzneimittel GmbH’s Agreement With Astellas Pharma Inc.
Freshfields Bruckhaus Deringer advised Cheplapharm Arzneimittel GmbH on the deal, Cheplapharm Arzneimittel GmbH (‘Cheplapharm’) signed an agreement with Astellas Pharma Inc., a Japan based pharmaceutical company,...